Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Network Type I Analysis

Type 1 network in which we propagated the absolute log regulation ratio abs(log(r/g)). We used the filtered lowest boundary of the confidence interval for the microarray measurement based and used the high confidence interaction map. Because type-I networks tend to favour highly connected proteins we tested a normalisation scheme in which we would run the network once with real values (the measured column) and once with simulated values where each measured point is set to 1 instead of the actual signal (the expected column). Afterwards we divided the measured value by the expected value. This normalisation scheme works to a certain extend but will lead to a variance that is directly related to the connectivity of each protein. In the end we dropped the use of Type-I networks due to the many technical problems they pose.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description measured expected final Hugo
Results: HTML CSV LaTeX
Showing element 902 to 951 of 3206 in total

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
measured\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
expected\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
final\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
902\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LIMBIC SYSTEM-ASSOCIATED MEMBRANE PROTEIN PRECURSOR (LSAMP). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.128336\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.494891\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.25932175\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
LSAMP\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
903\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
OPIOID BINDING PROTEIN/CELL ADHESION MOLECULE PRECURSOR (OBCAM) (OPIOID-BINDING CELL ADHESION MOLECULE) (OPCML). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.145116\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.560999\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.258674258\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
OPCML\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
904\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PEPTIDYLPROLYL ISOMERASE-LIKE 4; CYCLOPHILIN-TYPE PEPTIDYL-PROLYL CIS-TRANS ISOMERASE; PPIASE; SEROLOGICALLY DEFINED BREAST CANCER ANTIGEN NY-BR-18. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.227308\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.879442\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.258468438\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PPIL4\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
905\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SIMILAR TO GLUCOSAMINE-PHOSPHATE N-ACETYLTRANSFERASE (HYPOTHETICAL PROTEIN FLJ33258). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.29051\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.12415\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.258426367\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
GNPNAT1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
906\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DELTA-INTERACTING PROTEIN A (HEPATITIS DELTA ANTIGEN INTERACTING PROTEIN A). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.24009\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.929064\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.258421379\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CCDC85B\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
907\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ORPHAN NUCLEAR RECEPTOR NR6A1 (GERM CELL NUCLEAR FACTOR) (GCNF) (RETINOID RECEPTOR-RELATED TESTIS SPECIFIC RECEPTOR) (RTR). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.196675\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.76137\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.258317244\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
NR6A1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
908\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SEROLOGICALLY DEFINED COLON CANCER ANTIGEN 16. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0771492\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.298726\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.258260747\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
UTP14A\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
909\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NEUROTRIMIN PRECURSOR (HNT). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.159907\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.619267\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.258219799\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
910\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.233873\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.906259\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.258064196\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CCDC85A\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
911\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LYMPHOID ENHANCER BINDING FACTOR 1 (LEF-1) (T CELL-SPECIFIC TRANSCRIPTION FACTOR 1-ALPHA) (TCF1-ALPHA). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.427985\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.6585\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.258055472\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
LEF1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
912\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0349547\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.135465\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.258034917\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SLC37A2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
913\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GLYCEROL-3-PHOSPHATE TRANSPORTER (G-3-P TRANSPORTER) (G-3-P PERMEASE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0275088\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.106609\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.2580345\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SLC37A1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
914\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"PROLINE OXIDASE, MITOCHONDRIAL PRECURSOR (EC 1.5.3.-) (PROLINE DEHYDROGENASE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.198381\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.768816\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.258034432\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PRODH\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
915\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
INTERLEUKIN-4 INDUCED PROTEIN 1 PRECURSOR (FIG-1 PROTEIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.19466\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.754632\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.257953546\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
IL4I1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
916\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
VACUOLAR PROTEIN SORTING 33A (HVPS33A). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.132652\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.514271\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.257941824\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
VPS33A\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
917\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
VACUOLAR PROTEIN SORTING 33B (HVPS33B). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.104198\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.40396\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.25794138\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
VPS33B\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
918\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
VACUOLAR PROTEIN SORTING 11 (HVPS11) (PP3476). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.167384\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.648924\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.257940837\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
VPS11\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
919\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RAL GUANINE NUCLEOTIDE EXCHANGE FACTOR RALGPS1A. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0509651\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.197588\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.257936211\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RALGPS1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
920\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RAL-A EXCHANGE FACTOR RALGPS2. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.040067\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.155337\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.257935971\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RALGPS2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
921\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
STIP1 HOMOLOGY AND U-BOX CONTAINING PROTEIN 1; SEROLOGICALLY DEFINED COLON CANCER ANTIGEN 7; CARBOXY TERMINUS OF HSP70P-INTERACTING PROTEIN; HEAT SHOCK PROTEIN A BINDING PROTEIN 2 (C-TERMINAL). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.419455\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.6262\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.257935678\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
STUB1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
922\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ALPHA CRYSTALLIN C CHAIN (SMALL STRESS PROTEIN-LIKE PROTEIN HSP22) (E2IG1) (PROTEIN KINASE H11). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.208436\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.808729\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.257732813\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
HSPB8\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
923\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HEAT SHOCK 27 KDA PROTEIN (HSP 27) (STRESS-RESPONSIVE PROTEIN 27) (SRP27) (ESTROGEN-REGULATED 24 KDA PROTEIN) (28 KDA HEAT SHOCK PROTEIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.28007\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.08675\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.257713366\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
HSPB1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
924\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FATTY ACID DESATURASE 1; LINOLEOYL-COA DESATURASE (DELTA-6-DESATURASE)-LIKE 1; DELTA-5 DESATURASE; DELTA-5 FATTY ACID DESATURASE. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0378274\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.1468\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.257679837\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
925\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FATTY ACID DESATURASE 3; LINOLEOYL-COA DESATURASE (DELTA-6-DESATURASE)-LIKE 3; DELTA-6 FATTY ACID DESATURASE. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0325155\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.126186\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.25767914\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
FADS3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
926\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GERANYLGERANYL TRANSFERASE TYPE I BETA SUBUNIT (EC 2.5.1.-) (TYPE I PROTEIN GERANYL-GERANYLTRANSFERASE BETA SUBUNIT) (GGTASE-I-BETA). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0378747\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.146984\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.257679067\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PGGT1B\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
927\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 4 (SMAD 4) (MOTHERS AGAINST DPP HOMOLOG 4) (DELETION TARGET IN PANCREATIC CARCINOMA 4) (HSMAD4). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.303187\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.17661\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.257678415\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SMAD4\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
928\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FATTY ACID DESATURASE 2; LINOLEOYL-COA DESATURASE (DELTA-6-DESATURASE)-LIKE 2; DELTA-6 FATTY ACID DESATURASE. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0336801\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.130706\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.257678301\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
FADS2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
929\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PROTEIN TRANSLATION FACTOR SUI1 HOMOLOG (SUI1ISO1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.546429\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.12125\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.257597643\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
EIF1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
930\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DYNEIN LIGHT CHAIN 2. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.266007\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.03319\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.257461841\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
DYNLL2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
931\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SHORT COILED-COIL PROTEIN; SHORT COILED COIL PROTEIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0348108\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.135208\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.257461097\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SCOC\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
932\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LIMKAIN BETA 2. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.167087\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.649575\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.257225109\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CCDC92\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
933\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ADENYLOSUCCINATE LYASE (EC 4.3.2.2) (ADENYLOSUCCINASE) (ASL) (ASASE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.289435\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.12698\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.256823546\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ADSL\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
934\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CYCLIN C. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0849609\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.330921\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.256740733\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CCNC\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
935\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PROTEIN TARA (TRIO-ASSOCIATED REPEAT ON ACTIN) (HRIHFB2122). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0598365\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.233092\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.256707652\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
TRIOBP\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
936\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RHO INTERACTING PROTEIN 3. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0739754\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.28817\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.256707499\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
937\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
IMPORTIN ALPHA-6 SUBUNIT (KARYOPHERIN ALPHA-5 SUBUNIT). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1.37404\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5.35803\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.256444999\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
KPNA6\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
938\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CHOLINE O-ACETYLTRANSFERASE (EC 2.3.1.6) (CHOACTASE) (CHOLINE ACETYLASE) (CHAT). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0510434\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.199072\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.256406727\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CHAT\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
939\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
YIP1 INTERACTING FACTOR HOMOLOG; YIP1P-INTERACTING FACTOR; PUTATIVE RAB5-INTERACTING PROTEIN; PUTATIVE TRANSMEMBRANE PROTEIN 54TMP. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.121116\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.472359\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.256406674\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
YIF1A\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
940\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"METHYLMALONATE-SEMIALDEHYDE DEHYDROGENASE [ACYLATING], MITOCHONDRIAL PRECURSOR (EC 1.2.1.27) (MMSDH). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0637409\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.248593\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.256406657\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ALDH6A1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
941\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
VOLTAGE-GATED POTASSIUM CHANNEL BETA-3 SUBUNIT (K+ CHANNEL BETA-3 SUBUNIT) (KV-BETA-3). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0570543\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.222515\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.256406534\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
KCNAB3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
942\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0943614\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.368015\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.256406396\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
C1orf121\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
943\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
AFLATOXIN B1 ALDEHYDE REDUCTASE 2 (EC 1.-.-.-) (AFB1-AR 2). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0645005\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.251556\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.256406128\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
AKR7A3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
944\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ALPHA/BETA HYDROLASE DOMAIN CONTAINING PROTEIN 3; LUNG ALPHA/BETA HYDROLASE 3. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0204392\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.0797142\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.25640601\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ABHD3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
945\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
AFLATOXIN B1 ALDEHYDE REDUCTASE 1 (EC 1.-.-.-) (AFB1-AR 1) (ALDOKETOREDUCTASE 7). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0621197\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.242271\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.256405843\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
AKR7A2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
946\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
VOLTAGE-GATED POTASSIUM CHANNEL BETA-2 SUBUNIT (K+ CHANNEL BETA-2 SUBUNIT) (KV-BETA-2) (HKVBETA2). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0586077\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.228574\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.256405803\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
KCNAB2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
947\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GOLGI MEMBRANE PROTEIN SB140; SMOOTH MUSCLE CELL ASSOCIATED PROTEIN 5. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.174649\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.681143\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.256405777\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
YIPF5\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
948\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RAB ACCEPTOR 1 (PRENYLATED); PRENYLATED RAB ACCEPTOR 1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.13204\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.514965\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.256405775\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RABAC1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
949\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"OLIGORIBONUCLEASE, MITOCHONDRIAL PRECURSOR (EC 3.1.-.-) (SMALL FRAGMENT NUCLEASE) (CGI-114). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0337699\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.131705\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.256405603\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
REXO2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
950\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
VOLTAGE-GATED POTASSIUM CHANNEL BETA-1 SUBUNIT (K+ CHANNEL BETA-1 SUBUNIT) (KV-BETA-1). \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.0645342\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.251688\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.25640555\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
KCNAB1\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
951\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"10 KDA HEAT SHOCK PROTEIN, MITOCHONDRIAL (HSP10) (10 KDA CHAPERONIN) (CPN10). \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
HSPE1\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the bloody hugo identifier as demanded by the BMC Bioinformatics idiots
- http://analysis.yellowcouch.org/